Liver Summit 2025, Webinar Recording
The two-day summit offers a comprehensive examination of two pivotal aspects of liver disease
Vivian and Seymour Milstein Family Heart Center
The Columbia Liver Summit was recorded on Thursday, January 30-Friday, January 31, 2025.
Program Overview Day 1: The 6th Annual Pediatric Liver Disease and Transplantation
The overall goals of the activity is to learn about commonly encountered liver disease in children and understand the causes, signs, symptoms, risk factors, screening, as well as, innovative approaches to treatment and long-term management. The format of this program will consist of lectures and interactive discussions based on the overall goal of pediatric liver disease and transplantation.
Learning Objectives:
- Identify up-to-date management of pediatric liver disease
- Explain Metabolic disorders and their implications for pediatric liver transplantation.
- Understand state of the art management of pediatric liver transplant Identify Metabolic
Target Audience
This program has been designed for primary care physicians, Pediatric Gastroenterologists, Pediatric Surgeons, Transplant Surgeons, Nurses, Social Workers, Dieticians, Physician Assistants and any other clinicians involved in the management and treatment of pediatric liver disease and transplantation
Program Overview Day 2: The Third Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach
The Third Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach will be broken down into (3) sessions focusing on; screening, surveillance & evolving epidemiology to current treatments as well as a look to the future, evolving interventional options and a comprehensive understanding of transplant for the HCC patient. The format will consist of expert didactic lectures, case presentations, panel discussion with interactive audience Q&A.
Learning Objectives:
- Understand the recent changes in epidemiology of HCC and adjustments in screening and surveillance guidelines.
- Identify systemic chemotherapy, non-transplant surgical options, and patient management.
- Explain the most up-to-date oncology management of HCC including recent advances in immunotherapy
Target Audience
This program has been designed oncology providers, including surgeons, physicians, fellows, residents, nurse practitioners, and physician assistants who manage patients with hepatocellular carcinoma (HCC) across various clinical specialties including; general & transplant surgery, oncology, immunology, pulmonology, cardiology, gastroenterology, infectious disease, neuroscience & radiology.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians Assistants
PAs may claim a maximum of 11.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum 12 hours.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Refund Policy
Registration is limited and will be handled on a first-come, first-served basis. Telephone registrations/cancellations/refunds cannot be accepted.
Method of Participation
You will receive a confirmation email before the event with instructions for joining via Zoom and attending the Summit In-person instructions.
Tickets
MD, DO, PhD: Attending In-Person
Day 1: Pediatric Liver Disease and Transplantation
175.00 USD
Day 2: Hepatocellular Carcinoma in Adult Liver Cancer
175.00 USD
Both Days
300.00 USD
RN, NP, PA: Attending In- Person
Day 1: Pediatric Liver Disease and Transplantation
150.00 USD
Day 2: Hepatocellular Carcinoma in Adult Liver Cancer
150.00 USD
Both Days
250.00 USD
MD, DO, PhD: Attending Virtually
Day 1: Pediatric Liver Disease and Transplantation
150.00 USD
Day 2: Hepatocellular Carcinoma in Adult Liver Cancer
150.00 USD
Both Days
250.00 USD
RN, NP, PA: Attending Virtually
Day 1: Pediatric Liver Disease and Transplantation
100.00 USD
Day 2: Hepatocellular Carcinoma in Adult Liver Cancer
100.00 USD
Both Days
150.00 USD
Fellows, Residents, Students, VIP: Attending In-Person
Day 1: Pediatric Liver Disease and Transplantation
0.00 USD
Day 2: Hepatocellular Carcinoma in Adult Liver Cancer
0.00 USD
Both Days
0.00 USD
Fellows, Residents, Students, VIP: Attending Virtually
Day 1: Pediatric Liver Disease and Transplantation
0.00 USD
Day 2: Hepatocellular Carcinoma in Adult Liver Cancer
0.00 USD
Both Days
0.00 USD
Agenda
Thursday, January 30
8:00 AM
8:00 AM
Event Start
8:00 AM - 9:00 AM
8:00 AM - 9:00 AM
Day 1: Sixth Annual Pediatric Liver and Disease Transplantation
Registration | Breakfast | Vendor Exhibits
9:00 AM - 9:05 AM
9:00 AM - 9:05 AM
Welcome Remarks
Tomoaki Kato, MD
NYP/Columbia University Irving Medical Center
9:05 AM - 9:50 AM
9:05 AM - 9:50 AM
KEYNOTE ADDRESS: Unlocking the Potential of Gene Therapy to Manage
Moderator: Jean Emond MD, Mercedes Martinez, MD
Speaker: Lorenzo D'Antiga, MD
University of Milano - Bicocca
Hospital Papa Giovanni XXIII, Bergamo, Italy
9:50 AM - 10:05 AM
9:50 AM - 10:05 AM
Panel Discussion | Q&A Session
10:05 AM - 10:35 AM
10:05 AM - 10:35 AM
Session I: Overview of Metabolic Disorders in the Pediatric Patient
Speaker: Steven Lobritto, MD
NewYork-Presbyterian Morgan Stanley Children's Hospital
10:35 AM - 11:05 AM
10:35 AM - 11:05 AM
Session II: Metabolic Disorders Without Liver Injury
Speaker: John Bucuvalas, MD, FAASLD, FAST
Mount Sinai Kravis Children’s Hospital
11:05 AM - 11:35 AM
11:05 AM - 11:35 AM
Session III: Metabolic Disorders with Liver Injury
Speaker: Mercedes Martinez, MD
NewYork-Presbyterian Morgan Stanley Children's Hospital
11:35 AM - 12:00 PM
11:35 AM - 12:00 PM
Panel Discussion | Q&A Session
12:00 PM - 1:00 PM
12:00 PM - 1:00 PM
Lunch | Vendor Exhibits
1:00 PM - 1:40 PM
1:00 PM - 1:40 PM
JEOPARDY: GI Jeopardy Game: The Liver Edition
Moderator: Norberto Rodriguez-Beaz, MD
UT Southwestern Medical Center
Contestant: Adriana Perez, MD and Amanda Cantor, MD
NYP/Columbia University Irving Medical Center
1:40 PM
1:40 PM
SESSION IV: Management of Metabolic Disorders
Moderator: Adrina Perez, MD & Peter Liou, MD
1:40 PM - 2:00 PM
1:40 PM - 2:00 PM
Hyperammonemia Management
Speaker: Alejandro D. Iglesias, MD
NYP/Columbia University Irving Medical Center
2:00 PM - 2:20 PM
2:00 PM - 2:20 PM
Nutritional Management of Metabolic Patients
Speaker: Thandiwe C. Khonje, MA RD CDN
NYP/Columbia University Irving Medical Center
2:20 PM - 2:40 PM
2:20 PM - 2:40 PM
Liver Transplant Indications for Metabolic Disorders
Speaker: George V. Mazariegos, MD FACS
UPMC Children’s Hospital of Pittsburgh
2:40 PM - 3:00 PM
2:40 PM - 3:00 PM
Psychosocial Factors in Pediatric Liver Transplant Success: Enhancing Child and Family Adaptation
Speaker: Corrine N Ahrabi-Nejad, PHD
NYP/Columbia University Irving Medical Center
3:00 PM - 3:30 PM
3:00 PM - 3:30 PM
Panel Discussion | Q&A Session
3:30 PM - 3:55 PM
3:30 PM - 3:55 PM
Case Presentation #1
Moderator: Pooja Reddy Spector MD & Nathaly Llore, MD
Case Presentation #1
Speaker: Amanda Cantor, MD
3:55 PM - 4:00 PM
3:55 PM - 4:00 PM
Case Presentation #2
Case Presentation #2
Speaker: Mercedes Martinez, MD
4:00 PM - 4:45 PM
4:00 PM - 4:45 PM
Patient Testimonials
4:45 PM - 5:00 PM
4:45 PM - 5:00 PM
Closing Remarks
Tomoaki Kato, MD
NYP/Columbia University Irving Medical Center
Friday, January 31
9:00 AM - 9:30 AM
9:00 AM - 9:30 AM
Day 2: The Third Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach
Registration | Breakfast | Vendor Exhibits
9:30 AM - 9:35 AM
9:30 AM - 9:35 AM
Welcome Remarks
Tomoaki Kato, MD & Elizabeth C. Verna, MD, MS
Columbia University Irving Medical Center
9:35 AM
9:35 AM
Session 1: Update in HCC Epidemiology, Biomarkers and Screening
Moderators: Lorna Dove, MD and Peter Liou, MD
9:35 AM - 10:05 AM
9:35 AM - 10:05 AM
Update on Screening & Novel Biomarkers for HCC
Speaker: Neehar Parikh, MD
University of Michigan
10:05 AM - 10:25 AM
10:05 AM - 10:25 AM
Evolving Epidemiology of HCC and Disparities in Outcomes
Speaker: Meaghan Phipps, MD
Columbia University Irving Medical Center
10:25 AM - 10:45 AM
10:25 AM - 10:45 AM
Novel Mechanisms of HCC Pathogenesis
Robert Schwabe, MD
Professor of Medicine
Columbia University Irving Medical Center
10:45 AM - 11:15 AM
10:45 AM - 11:15 AM
Diagnostic Approach to Solid Liver Lesions & LIRADS Criteria
Victoria Chernyak, MD, MS, FSAR, ESGAR, FSABI, FACR
Professor of Radiology
NYP/Columbia University Irving Medical Center
11:15 AM - 11:35 AM
11:15 AM - 11:35 AM
Case Presentations and Panel Discussion
11:35 AM - 11:45 AM
11:35 AM - 11:45 AM
Q&A Session
11:45 AM - 12:30 PM
11:45 AM - 12:30 PM
AM Break | Exhibit Hall
12:15 PM - 1:00 PM
12:15 PM - 1:00 PM
KEYNOTE ADDRESS: Immunotherapy for HCC: Current Recommendations & Future Directions
Ruth He, MD
12:30 PM
12:30 PM
Session 2: Multi-Disciplinary & Multi-Modality Treatment for HCC
Moderators: Meaghan Phipps, MD and Jason Hawksworth, MD
12:30 PM - 1:15 PM
12:30 PM - 1:15 PM
KEYNOTE ADDRESS Immunotherapy for HCC: Current Recommendations & Future Directions
Speaker: Ruth He, MD
Georgetown University
1:15 PM - 1:35 PM
1:15 PM - 1:35 PM
Interventional Radiology Approaches to HCC Treatments: TACE, Y90, Ablation, Histosonic
Speaker: Jonathan Susman, MD
Columbia University Irving Medical Center
1:35 PM - 1:55 PM
1:35 PM - 1:55 PM
Surgical Approach to HCC: Resection and Transplant
Speaker: Jason Hawksworth, MD
Columbia University Irving Medical Center
1:55 PM - 2:35 PM
1:55 PM - 2:35 PM
Moderated Case Presentation and Panel Discussion
Topic: Treatment of HCC: Systemic Therapy, IR-Based Treatment, and Liver Transplantation
Moderator: Alyson Fox, MD, MS
Associate Professor of Medicine, Medical Director of Liver Transplantation
Columbia University Irving Medical Center
2:35 PM - 2:45 PM
2:35 PM - 2:45 PM
Break
2:45 PM
2:45 PM
Session 3: Update on the Diagnosis & Management of Cholangiocarcinoma (CCA) Moderators: Jean Emond, MD, and Ruth He, MD, PhD
Moderators: Jean Emond, MD, and Ruth He, MD, PhD
2:45 PM - 3:05 PM
2:45 PM - 3:05 PM
Epidemiology and Pathogenesis of CCA
Speaker: Gulam Manji, MD, PhD
Columbia University Irving Medical Center
3:05 PM - 3:35 PM
3:05 PM - 3:35 PM
Surgical Approaches to CCA Treatment
Speaker: Jean Emond, MD
Columbia University Irving Medical Center
3:35 PM - 3:55 PM
3:35 PM - 3:55 PM
Update on Systemic Therapies in CCA Management
Speaker: Lipika Goyal, MD (Virtual)
Standford Medicine
3:55 PM - 4:15 PM
3:55 PM - 4:15 PM
Case Presentations and Panel Discussion
4:15 PM - 4:25 PM
4:15 PM - 4:25 PM
Q&A Session | Panel Discussion
4:25 PM - 4:30 PM
4:25 PM - 4:30 PM
Closing Remarks
Tomoaki Kato, MD & Elizabeth C. Verna, MD, MS
Columbia University Irving Medical Center
Friday, April 11
9:46 AM
9:46 AM
Event End
